| Ashley Grace Huot, DNP, FNP-C | |
|
1220 Sheyenne St, West Fargo, ND 58078-2637 | |
| (701) 234-4445 | |
| Not Available |
| Full Name | Ashley Grace Huot |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1220 Sheyenne St, West Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700291895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R34451 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
Financially strapped state and local governments are saving billions of dollars on health insurance by cutting back on free coverage for employees and raising worker contributions, a USA Today analysis finds. Government workers still enjoy more generous health benefits than privately employed workers but the advantage has narrowed from $1,523 in 2007 to $891 in 2012, adjusted for inflation, federal data show.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.
EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
A group of University of Illinois researchers, led by Centennial Chair Professor of the Department of Chemical and Biomolecular Engineering Huimin Zhao, has demonstrated the use of an innovative DNA engineering technique to discover potentially valuable functions hidden within bacterial genomes.
› Verified 9 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
Financially strapped state and local governments are saving billions of dollars on health insurance by cutting back on free coverage for employees and raising worker contributions, a USA Today analysis finds. Government workers still enjoy more generous health benefits than privately employed workers but the advantage has narrowed from $1,523 in 2007 to $891 in 2012, adjusted for inflation, federal data show.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.
EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
A group of University of Illinois researchers, led by Centennial Chair Professor of the Department of Chemical and Biomolecular Engineering Huimin Zhao, has demonstrated the use of an innovative DNA engineering technique to discover potentially valuable functions hidden within bacterial genomes.
› Verified 9 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
Financially strapped state and local governments are saving billions of dollars on health insurance by cutting back on free coverage for employees and raising worker contributions, a USA Today analysis finds. Government workers still enjoy more generous health benefits than privately employed workers but the advantage has narrowed from $1,523 in 2007 to $891 in 2012, adjusted for inflation, federal data show.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.
EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
A group of University of Illinois researchers, led by Centennial Chair Professor of the Department of Chemical and Biomolecular Engineering Huimin Zhao, has demonstrated the use of an innovative DNA engineering technique to discover potentially valuable functions hidden within bacterial genomes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Grace Huot, DNP, FNP-C 1220 Sheyenne St, West Fargo, ND 58078-2637 Ph: (701) 234-4445 | Ashley Grace Huot, DNP, FNP-C 1220 Sheyenne St, West Fargo, ND 58078-2637 Ph: (701) 234-4445 |
News Archive
Financially strapped state and local governments are saving billions of dollars on health insurance by cutting back on free coverage for employees and raising worker contributions, a USA Today analysis finds. Government workers still enjoy more generous health benefits than privately employed workers but the advantage has narrowed from $1,523 in 2007 to $891 in 2012, adjusted for inflation, federal data show.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.
EntreMed, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's lead oncology drug candidate, ENMD-2076, for the treatment of acute myeloid leukemia (AML).
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
A group of University of Illinois researchers, led by Centennial Chair Professor of the Department of Chemical and Biomolecular Engineering Huimin Zhao, has demonstrated the use of an innovative DNA engineering technique to discover potentially valuable functions hidden within bacterial genomes.
› Verified 9 days ago
James Troy Upton, APRN, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3306 Sheyenne St Ste 216, West Fargo, ND 58078 Phone: 701-532-1731 Fax: 701-532-1940 | |
Cynthia Nicole Vingelen, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1220 Sheyenne St, West Fargo, ND 58078 Phone: 701-234-4445 | |
Patricia K Slyter, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1401 13th Ave E, West Fargo, ND 58078 Phone: 701-364-0060 Fax: 701-364-0065 | |
Dr. Jenna Rose Wallace, DNP, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1220 Sheyenne St, West Fargo, ND 58078 Phone: 701-234-4445 Fax: 701-234-4456 | |
Cassie Marie Moores Kristensen, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1417 12th Street Ct, West Fargo, ND 58078 Phone: 415-278-1574 | |
Molly Christine Mcmanus, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1401 13th Avenue East, West Fargo, ND 58078 Phone: 701-364-5722 | |
Marjorie Masten, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1401 13th Ave E, West Fargo, ND 58078 Phone: 701-364-5751 |